China National Medicines Corporation Ltd. Revenue Per Share for the year ending December 31, 2024: USD 9.18

China National Medicines Corporation Ltd. Revenue Per Share is USD 9.18 for the year ending December 31, 2024, a -1.00% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • China National Medicines Corporation Ltd. Revenue Per Share for the year ending December 31, 2023 was USD 9.28, a 6.17% change year over year.
  • China National Medicines Corporation Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 8.74, a -9.85% change year over year.
  • China National Medicines Corporation Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 9.69, a 18.22% change year over year.
  • China National Medicines Corporation Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 8.20, a -2.56% change year over year.
Key Data
Date Revenue Per Share Free Cash Flow Per Share Dividend Per Share Debt to Equity Ratio